Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 5


Figure 5 The effects of different concentrations of recombinant human neutrophil-activating peptide (rhNAP)-2 on E-selectin (A), vascular cellular adhesion molecule (VCAM)-1 (B), monocyte chemoattractant protein (MCP)-1 (C), and interleukin (IL)-8 (D) in human umbilical vein endothelial cells after culturing for 5 (A and B) and 24 h (C and D). (E) Shows the effect of neutralizing antibodies against CXCR1 and CXCR2 (p = 0.06) receptors on the rhNAP-2-induced (250 ng/ml) release of IL-8 in human umbilical vein endothelial cells supernatants after culturing for 24 h. No down-regulatory effect was seen when a control antibody of the same isotype and concentration was added (data not shown). (F) Shows the ability of a neutralizing antibody against NAP-2 and a control antibody of the same isotype and concentration (IgG1), to attenuate the effect of the platelet extract-mediated increase of IL-8 release in human umbilical vein endothelial cell supernatants after culturing for 5 h. Data are mean values ± SEM of 6 separate experiments. *p < 0.05 and **p < 0.001 versus unstimulated (Unstim) cells; #p < 0.05 versus cells stimulated with rhNAP-2 (E) or platelet extract (PE) (F). The Wilcoxon signed rank test (simple comparisonwise p values) was used for statistical comparisons. OD = optical density.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement